Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care

Active Grant Awards

Dr. Vladimir Badovinac received a five-year NIH MIRA(Maximizing Investigators' Research Award) R35 award from the National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS). The title of the project is Cellular and Molecular Mechanisms Controlling Sepsis-induced Immunoparalysis State. The total direct costs for this award are $1,250,000 and the funding period for this project is February 1, 2020 through January 31, 2025.

Drs. Vladimir Badovinac and John Harty received a five-year R01 grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The grant is entitled Memory CD8 T Cell Localization and Protection from Influenza. The total direct costs for this award are $1,489,525 and the funding period for this project is January 1, 2020 through December 31, 2024.

Dr. Sterling Ortega received a one year pilot grant from the National MS Society. The title of the project is The Neuro-reparative Role of Myelin-specific CD8 T-cells in EAE Recovery. The total direct costs for this award are $50,000 and the funding period for this project is February 1, 2020 through January 31, 2021.

Dr. Andrean Simons-Burnett received a four-year Merit Award from the Department of Veteran Affairs. The title of the project is IL-1-based immunotherapy in HNSCC. The total direct costs for this award are $650,000. The funding period for this project is January 1, 2020 to December 31, 2023.

Dr. Munir Tanas received a five-year NIH R01 grant from the National Institutes of Health/National Cancer Institute (NIH/NCI). The title of the project is Epigenetic Modulation of the TAZ-CAMTA1 Transcriptional Program by the Ada2a-containing Histone Acetyltransferase (ATAC) Complex. The total direct costs for this award are $1,143,750. The entire period for this project is December 15, 2019 through November 30, 2024.

Dr. Chen Zhao received a five-year NIH R01 grant from the National Institutes of Health/National Cancer Institute (NIH/NCI). The title of the project is Heat Shock Transcription Factor 1 (HSF1) Specifically Regulates AML Stem Cell Self-Renewal. The total direct costs for this award are $ 1,202,070. The entire period for this project is December 15, 2019 through November 30, 2024.

Dr. Marco Hefti received a five-year NIH K23 grant from the National Institutes of Health/ National Institute of Neurological Disease and Stroke (NIH/NINDS). The title of the project is Novel Tau-based Diagnostics for Neonatal Hypoxic-ischemic Injury. The total direct costs for this award are $880,000. The funding period for this project is September 30, 2019 to August 31, 2024.

Dr. Nitin Karandikar received a Shared Equipment Award from the Department of Veteran Affairs. The grant is entitled ShEEP Request for Cytek AURORA Spectral Flow Cytometer. The total direct costs for this award are $422,500. The entire period for this award is September 1, 2019 through September 30, 2020.

Dr. Vladimir Badovinac received a two-year NIH R21 grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of the project is Differentiation of Pathogen-Specific Memory CD8 T Cell Responses. The total direct costs for this award are $275,000. The entire period for this project is May 22, 2019 through April 30, 2021.

Dr. Dao-Fu Dai received a five-year NIH K08 grant from the National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI). The title of the project is The Role of Energy Sensor Signaling in Mitochondrial Cardiomyopathy. The total direct costs for this award are $803,140. The funding period for this project is February 1, 2019 to December 31, 2023.

Dr. Chen Zhao received a four-year Merit Award grant from the Department of Veteran Affairs. The title of this project is Synergy of NF-kB and Notch signaling in B cell lymphomatous transformation and B cell plasticity. The total direct costs for this award are $650,000. The funding period for this project is January 1, 2019 to December 31, 2022.

Drs. Vladimir Badovinac and Kevin Legge were awarded a Carver Trust Collaborative Pilot Grant from the College of Medicine. The title of the project is Impairment and Recovery of Dendritic Cell Immunity after Sepsis. The total funding for this award is $50,000 and the project period is July 1, 2018 through June 30, 2020.

Dr. Michael Knudson received contract award funding from Terumo Corporation as part of a multi-institutional study investigating platelet transfusions. The title of the award is Clinical Effectiveness of Conventional Versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia (MIPLATE). The total direct funding for this award is $1,100,000 and the project period is December 13, 2017 through December 31, 2020.

Dr. Ashu Mangalam received grant funding from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of the grant is Linking diet, gut microbiota and autoimmune disease: Bacteria induced phytoestrogen metabolites impact immune function in Experimental Autoimmune Encephalitis. The total direct funding for this award is $1,000,000 and the project period is February 15, 2018 through January 31, 2023.

Drs. Kevin Legge and Thomas Waldschmidt received grant funding from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this grant is Nanovaccine-Mediated Immune Protection Against Influenza Virus. The total direct funding for this award is $2,226,287 and the project period is June 1, 2017 through May 31, 2022.

Dr. Hasem Habelhah received a two-year NIH R21 grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS). The title of this project is HtrA2-mediated RIP1 Cleavage Regulates Neuronal Inflammation and Death. The total direct costs for this award are $275,000. The entire period for this project is June 1, 2017 through May 31, 2020.

Dr. Nitin Karandikar received Merit Award grant funding from the Department of Veteran Affairs. The title of this project is Immunotherapeutic Regulatory CD8 T cells in Autoimmune Demyelinating Disease. The total direct costs for this award are $650,000. The entire period for this project is July 1, 2017 through June 30, 2021.

Dr. Jian Zhang received grant funding from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is Regulation of Innate Immune System Sensing of C. Albicans Infections. The total direct costs for this award are $1,395,000. The entire period for this project is April 1, 2016 through March 31, 2021.

Dr. Jian Zhang received grant funding from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is NEDD4 in T Helper Cell Development and Autoimmunity. The total direct costs for this award are $1,657,000. The entire period for this project is June 20, 2016 through May 31, 2021.

Dr. Jian Zhang received grant funding from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is Role of Protein Ubiquitination in Sepsis. The total direct costs for this award are $1,125,000. The entire period for this project is June 24, 2016 through May 31, 2021.

Dr. Munir Tanas received Merit Award grant funding from the Department of Veteran Affairs. The title of this project is Upstream regulation of TAZ and YAP in sarcomas: towards combinatorial therapy targeting the Hippo Pathway. The total direct costs for this award are $631,572. The entire period for this project is January 1, 2017 through December 31, 2020.

Dr. Nitin Karandikar received grant funding from the National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is Immune Dysregulation During Multiple Sclerosis Relapse. The total direct costs for this award are $2,401,480. The period for this project is May 19, 2016 through April 30, 2021.

Dr. Vladimir Badovinac received grant funding from the National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS). The title of this project is Impairment and Recovery of CD8 T Cell Responses after Sepsis. This funding total is $1,203,872 and is for the period of September 1, 2015 and should be complete by July 31, 2020.

Dr. Hasem Habelhah received grant funding from the US Department of Defense/Congressionally Directed Medical Research Program (DOD/CDMRP). The title of this project is Therapeutic Efficacy of Combined TBK1 and AKT Inhibition in Breast Cancer. This funding total is $531,875 and is for the period of September 1, 2015 and should be complete by August 31, 2019.

Dr. Vladimir Badovinac received a Co-PI grant funding with Dr. John Harty from the Department of Microbiology.  The grant was awarded from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID).  The title of this project is Memory CD8 T cell localization and protection from influenza.   This funding total is $1,900,000 and is for the period of November 1, 2014 and should be complete by October 31, 2019.

Dr. Andrean Simons-Burnett received grant funding from the National Institutes of Health/National Institute of Dental & Craniofacial Research (NIH/NIDCR). The title of this project is Role of inflammation in resistance to EGFR inhibitors in head and neck cancer. This funding total is $1,878,808 and is for the period of July 2, 2014 and should be complete by April 30, 2020.